Here's why the epidemic strain of C. difficile is so deadly—and a way to stop it

Here's why the epidemic strain of C. difficile is so deadly -- and a way to stop it
Study co-authors Stacey Burgess and Mahmoud Saleh and lead author Carrie Cowardin in the Petri lab at the University of Virginia School of Medicine. Dr. Cowardin led the team that discovered that the strain of C. difficile causing the current epidemic kills a key white blood cell whose role is to protect the gut from infection. Credit: Courtesy Bill Petri, University of Virginia School of Medicine

A new, epidemic strain of C. difficile is proving alarmingly deadly, and new research from the University of Virginia School of Medicine not only explains why but also suggests a way to stop it.

Until now, scientists have not understood what made this strain worse than other of the bacteria, the most common cause of hospital-acquired infections. The new strain kills up to 15 percent of infected patients, including those who receive antibiotics, and has become increasingly common over the last 15 years. This has prompted the federal Centers for Disease Control and Prevention to label it an "urgent threat."

A Potent Toxin

The finding comes from the lab of Bill Petri, MD, PhD, chief of UVA's Division of Infectious Diseases and International Health, and a team of international collaborators. PhD student Carrie A. Cowardin was working in Petri's lab when she discovered the diabolical mechanisms this strain of C. diff uses to overcome the body's natural defenses.

The strain is so deadly because it produces a toxin that kills protective cells, called eosinophils, found in the gut, Cowardin found. By destroying the gut's natural barrier, the bacteria can spread inflammation throughout the body. "We think that this toxin makes disease more severe by killing beneficial eosinophils, which seem to play an important role in promoting a healthy during C. difficile infection. When the eosinophils were depleted with an antibody or by the toxin, we saw dramatically increased inflammation. Restoring eosinophils by transferring them from a mouse that cannot recognize the toxin prevented the damage inflicted by the epidemic strain," said Cowardin, now a postdoctoral fellow at Washington University in St. Louis. "This builds on previous work in our lab showing that are beneficial and suggests that one reason this strain causes such severe disease is due to its ability to kill these cells."

Further, Cowardin discovered exactly how the toxin works, and how well it functions in this role. The toxin, she determined, requires a particular human protein that recognizes bacteria, a protein that plays a key role in the immune response. In short, C. diff is subverting the body's natural defenses to overcome those defenses.

This understanding of the 's action could be of great importance, as blocking it can rescue the protective cells in the gut. And that approach could lead to a new treatment to stop this of C. diff in its tracks.

"Nearly every day that I care for patients I am faced with this potentially deadly infection," Petri said. "Carrie Cowardin's discovery of why this strain of C. diff is so dangerous, and most importantly how to combat it, is a huge and most needed advance."


Explore further

Allergy-causing 'bad guy' cells unexpectedly prove life-saving in C. difficile

More information: Carrie A. Cowardin et al, The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia, Nature Microbiology (2016). DOI: 10.1038/nmicrobiol.2016.108
Journal information: Nature Microbiology

Citation: Here's why the epidemic strain of C. difficile is so deadly—and a way to stop it (2016, August 1) retrieved 22 April 2019 from https://phys.org/news/2016-08-epidemic-strain-difficile-deadlyand.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
390 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more